This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Müller, H. L. Articles by Sörensen, N. Search for Related Content PubMed PubMed Citation Articles by Müller, H. L. Articles by Sörensen, N.

Melatonin Secretion and Increased Daytime Sleepiness in Childhood Craniopharyngioma Patients

Department of Pediatrics, Zentrum für Kinder- und Jugendmedizin, Klinikum Oldenburg gGmbH (H.L.M.), 26133 Oldenburg, Germany; Children’s Hospital Passau (G.H.), 94032 Passau, Germany; Departments of Pediatrics (B.W.) and Pediatric Neurosurgery (N.S.), University of Wurzburg, 97080 Wurzburg, Germany; and Institute for Medical Biometry, Epidemiology, and Informatics, University of Mainz (A.F.), 55101 Mainz, Germany

Address all correspondence and requests for reprints to: Hermann L. Müller, M.D., Children’s Hospital, Department of Pediatrics, Klinikum Oldenburg gGmbH, Cloppenburgerstrasse 363, 26133 Oldenburg, Germany. E-mail: . mueller.hermann{at}kliniken-oldenburg.de

Abstract

Craniopharyngioma is a rare dysontogenetic benign tumor. Patients frequently suffer from endocrine deficiencies, sleep disturbances, and obesity due to pituitary and hypothalamic lesions. A self-assessment daytime sleepiness questionnaire (German version of the Epworth Sleepiness Scale) was used to evaluate 79 patients with childhood craniopharyngioma. Because hypothalamic lesions may explain daytime sleepiness in craniopharyngioma patients, salivary melatonin and cortisol concentrations were examined in obese and nonobese craniopharyngioma patients (n = 79), patients with hypothalamic pilocytic astrocytoma (n = 19), and control subjects (n = 30).

Using a general linear model procedure analyzing the influence of body mass index (BMI) and tumor diagnosis on diurnal salivary melatonin, we found that morning salivary melatonin levels were related to BMI (by F test, P = 0.004) and tumor diagnosis (by F test, P = 0.032). Also for nighttime salivary melatonin levels significant relations with BMI (by F test, P < 0.001) and tumor diagnosis (by F test, P = 0.025) were detectable. Melatonin concentrations in saliva of craniopharyngioma patients collected at night or in the morning showed a negative correlation (night: Spearman’s = -0.42; P = 0.001; morning: Spearman’s = -0.31; P = 0.020) with the patient’s Epworth Sleepiness Scale score. Severely obese craniopharyngioma patients and severely obese hypothalamic tumor patients had similar patterns of melatonin secretion. Differences in terms of diurnal salivary cortisol concentrations were not detectable when patient groups and controls were compared.

We speculate that hypothalamic lesions might be responsible for both obesity and daytime sleepiness. As decreased nocturnal melatonin levels were associated with increased daytime sleepiness, BMI, and hypothalamic tumor diagnosis, further studies on the beneficial effects of melatonin substitution on daytime sleepiness and weight control in these patients are warranted.

This article has been cited by other articles:

				J. Lipton, J. T. Megerian, S. V. Kothare, Y-J Cho, T. Shanahan, H. Chart, R. Ferber, L. Adler-Golden, L. E. Cohen, C. A. Czeisler, et al. MELATONIN DEFICIENCY AND DISRUPTED CIRCADIAN RHYTHMS IN PEDIATRIC SURVIVORS OF CRANIOPHARYNGIOMA Neurology, July 28, 2009; 73(4): 323 - 325. [Full Text] [PDF]

				M. G. Shaikh, R. G. Grundy, and J. M. W. Kirk Reductions in Basal Metabolic Rate and Physical Activity Contribute to Hypothalamic Obesity J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2588 - 2593. [Abstract] [Full Text] [PDF]

				A. A. van der Klaauw, O. M. Dekkers, A. M. Pereira, K. W. van Kralingen, and J. A. Romijn Increased Daytime Somnolence despite Normal Sleep Patterns in Patients Treated for Nonfunctioning Pituitary Macroadenoma J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3898 - 3903. [Abstract] [Full Text] [PDF]

				H. L. Muller, A. Emser, A. Faldum, G. Bruhnken, N. Etavard-Gorris, U. Gebhardt, R. Oeverink, R. Kolb, and N. Sorensen Longitudinal Study on Growth and Body Mass Index before and after Diagnosis of Childhood Craniopharyngioma J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3298 - 3305. [Abstract] [Full Text] [PDF]

				K. J. Harz, H. L. Muller, E. Waldeck, V. Pudel, and C. Roth Obesity in Patients with Craniopharyngioma: Assessment of Food Intake and Movement Counts Indicating Physical Activity J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5227 - 5231. [Abstract] [Full Text] [PDF]

				G. M. Rosen, A. E. Bendel, J. P. Neglia, C. L. Moertel, and M. Mahowald Sleep in Children With Neoplasms of the Central Nervous System: Case Review of 14 Children Pediatrics, July 1, 2002; 112(1): e46 - 54. [Abstract] [Full Text] [PDF]